Karl Egerer

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Katharina Hanke, Claudia Brückner, Cornelia Dähnrich et al. · Arthritis Research & Therapy · 2009 · 448 citations · Full text

Life Sciences, Immunology, Pathology +14

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

Stefan D. Anker, Karl Egerer, Hans‐Dieter Volk et al. · The American Journal of Cardiology · 1997 · 395 citations

Veterinary Medicine, Cardiology, Immunology +15

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

Holger Bang, Karl Egerer, Anke Gauliard et al. · Arthritis & Rheumatism · 2007 · 292 citations

Life Sciences, Immunology, Internal Medicine +17

Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study

J. Detert, H. Bastian, Joachim Listing et al. · Annals of the Rheumatic Diseases · 2012 · 188 citations

Life Sciences, Clinical Sciences, Pharmacotherapy +17

Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma

Christian Jakob, Karl Egerer, Peter Liebisch et al. · Blood · 2006 · 127 citations

Life Sciences, Molecular Biology, Oncology +16